
Icon’s benign growth into the UK cancer market
Brisbane-based cancer-care provider, Icon, has bought UK chemotherapy compounding company Pharmaxo, further expanding its presence in the global growth industry. The purchase marks another milestone for Icon which was founded in Toowoomba, 120km west of Brisbane, in 2007 by a group of doctors and radiotherapists hoping to make advanced cancer treatments available to regional Australians. […]